JG
VYGR icon

Jain Global’s Voyager Therapeutics VYGR Stock Holding History

Jain Global’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,669
Closed -$41.9K – 1689
2025
Q4 		$41.9K Sell
10,669
-17,435
-62% -$77.1K ﹤0.01% 1170
2025
Q3 		$131K Buy
28,104
+8,600
+44% +$31.1K ﹤0.01% 925
2025
Q2 		$60.7K Buy
+19,504
New +$62.9K ﹤0.01% 1082

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jain Global's VYGR Position: Q1 2026 in Review

Jain Global sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 10,669 shares — an estimated $41.9K sold.

Jain Global first reported a position in VYGR in Q2 2025 and held it in 3 quarters. The position peaked at $131K in Q3 2025. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Jain Global reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 10,669 Voyager Therapeutics shares in Q1 2026, an estimated $41.9K.
  • Jain Global first reported a position in Voyager Therapeutics in Q2 2025 and held it in 3 quarters.
  • Jain Global's Voyager Therapeutics position peaked at $131K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.